Acquiring Company
Boston Scientific
Acquired Company
Obsidio
Description
Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEMTM) technology used for embolization of blood vessels in the peripheral vasculature.
Quick answer
Boston Scientific is acquiring Obsidio, announced August 15, 2022. Boston Scientific is based in Marlborough, Massachusetts, United States.
- How much did Boston Scientific pay for Obsidio?
- The deal value was not disclosed.
- What does Boston Scientific do?
- Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
- Where are Boston Scientific and Obsidio based?
- Boston Scientific is based in Marlborough, Massachusetts, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Conmed Completes Acquisition Of Biorez, Inc. (August 9, 2022)
- Conmed Announces Definitive Agreement To Acquire Biorez, Inc. (August 1, 2022)
- Bristol Myers Squibb And Turning Point Therapeutics Announce Expiration Of Hsr Act Waiting Period And Clearance From Federal Cartel Office Of Germany Related To Pending Acquisition Of Turning Point Therapeutics (August 16, 2022)
- Bristol Myers Squibb Completes Acquisition Of Turning Point Therapeutics, Expanding Precision Oncology Portfolio (August 17, 2022)
- Azenta Announces Agreement To Acquire B Medical Systems (August 8, 2022)
- Teleflex Completes Acquisition Of Standard Bariatrics (September 28, 2022)
Who to call at Boston Scientific, and when
When Boston Scientific changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Boston Scientific raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Boston Scientific, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Boston Scientific. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Boston Scientific makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Obsidio?
Obsidio was acquired by Boston Scientific, based in Marlborough. The deal was reported on August 15, 2022. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific is publicly traded (BSX) and operates in Manufacturing.
When did Boston Scientific acquire Obsidio?
Boston Scientific's acquisition of Obsidio was reported on August 15, 2022. Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEMTM) technology used for embolization of blood vessels in the peripheral vasculature. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Obsidio do?
Just another WordPress site It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.